4Morgan C,Lunt M,Brightwell H,et al.Contribution of patient related differences to multidrug resistance in rheumatoid arthritis.Ann Rheum Dis,2003,62:15-19.
5Arceci RJ.Clinical signficance of P-protein in multidrug resistance malignancies.Blood,1993,81:2215-2222.
6Sonneveld P.Multidrug resistance in haematology malignancies.Jinter Med,2000,247:521-534.
7Marchetti S.Concise review:clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1,P-glycoprotein).Oncologist,2007,12:927-994.
8Tsujimura S.Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.Ann Rheum Dis,2008,67:380-388.
9Bologna C,Sany J.Expression of a multidmg resistance gene in human rheumatoid synovium.Bheumatol Int,1995,15:83-86.
